Genetic profiling of CAH Egyptian children: rapid guide to clinical interpretation of common mutations
- 1 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Endocrinological Investigation
- Vol. 44 (1), 83-93
- https://doi.org/10.1007/s40618-020-01271-z
Abstract
Objectives The prevalence of CAH in Egypt is reported to be ten times more than that of the worldwide prevalence. The study aimed at genetic screening of children diagnosed with 21-alpha hydroxylase deficiency congenital adrenal hyperplasia (21OHD-CAH). In addition, the study offers a rapid and easy guide for clinical reporting of common mutations for endocrinologists. Methods A cohort of 174 unrelated Egyptian children with 21OHD-CAH were screened for 11 common CYP21A2 gene mutations using a strip hybridization assay, and then, bioinformatics analysis was done to report the pathogenicity of the common mutations for clinical classification. Results The most common mutations were I2 splice and p.Q318X. Deletions/conversions comprised 45.9% of the cohort, whereas 7.4% of the cases were negative for all mutations. The least positively detected point mutations were p.P453S, cluster E6, p.R483P, and p.L307FS, which were detected in fewer than 5% of cases. Conclusion Strip hybridization assay is a rapid screening tool for the diagnosis of CAH. The authors hypothesized an easy and rapid scheme for clinical interpretation of the strip results to gain the highest value of the strip in diagnosis.Keywords
Funding Information
- STDF (4671)
This publication has 31 references indexed in Scilit:
- Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiencyProceedings of the National Academy of Sciences of the United States of America, 2013
- Reverse-hybridization assay for rapid detection of common CYP21A2 mutations in dried blood spots from newborns with elevated 17-OH progesteroneClinica Chimica Acta; International Journal of Clinical Chemistry, 2012
- Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyJournal of Clinical Endocrinology & Metabolism, 2011
- Congenital Adrenal Hyperplasia in Alexandria, Egypt: A High Prevalence Justifying the Need for a Community-based Newborn Screening ProgramJournal of Tropical Pediatrics, 2010
- Variations in the promoter of CYP21A2 gene identified in a Chinese patient with simple virilizing form of 21‐hydroxylase deficiencyClinical Endocrinology, 2009
- A Simple and Robust Quantitative PCR Assay to Determine CYP21A2 Gene Dose in the Diagnosis of 21-Hydroxylase DeficiencyClinical Chemistry, 2007
- An intron 1 splice mutation and a nonsense mutation (W23X) in CYP21 causing severe congenital adrenal hyperplasiaHuman Genetics, 1996
- Molecular pathology of 21‐hydroxylase deficiencyJournal of Inherited Metabolic Disease, 1994
- Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization and Southern blotHuman Genetics, 1994
- Nonsense mutation causing steroid 21-hydroxylase deficiency.JCI Insight, 1988